450 filings
Page 20 of 23
CT ORDER
e7ry1970hgtn ndg6
23 Jun 15
Confidential treatment order
12:00am
424B3
hqpkm
3 Jun 15
Prospectus supplement
12:00am
8-K/A
6h3oq1shqbspx hn
2 Jun 15
Financial Statements and Exhibits
12:00am
424B3
rgswjv
28 May 15
Prospectus supplement
12:00am
8-K
ixqqq 9f6hwtf
28 May 15
Recro Pharma to Present at the Jefferies 2015 Global Healthcare Conference
12:00am
424B3
mb4ia
13 May 15
Prospectus supplement
12:00am
8-K
i4gxzs
12 May 15
Recro Pharma Reports First Quarter 2015 Financial Results
12:00am
ARS
mwj17yv2ycl0vnxtj
30 Apr 15
Annual report to shareholders
12:00am
DEFA14A
efu4r1i ukcx8ea4
29 Apr 15
Additional proxy soliciting materials
12:00am
DEF 14A
2mv xw9gzk83dfxg6
29 Apr 15
Definitive proxy
12:00am
D
x73e28us yxene8pvq4
23 Apr 15
$7.78M in options, sold $7.78M, 2 investors
12:00am
424B3
a3jm6mkt1xksado
17 Apr 15
Prospectus supplement
12:00am
CT ORDER
vrzybhak k0uu
17 Apr 15
Confidential treatment order
12:00am
8-K
gvokiawgyj9l9 28i4
16 Apr 15
Recro Pharma Completes Acquisition of IV/IM Meloxicam and cGMP
12:00am
8-K
qbpq6x62xdn
10 Apr 15
Recro Pharma Announces Update on On-Going Phase II Clinical
12:00am
424B3
2d96ilgda576cby
10 Apr 15
Prospectus supplement
12:00am
424B3
pj2qfuz
2 Apr 15
Prospectus supplement
12:00am
10-K
6ip5ps vx0ic
25 Mar 15
Annual report
12:00am
8-K
9nmo7 85gc707
25 Mar 15
Recro Pharma Reports Fourth Quarter and Full Year 2014 Financial Results
12:00am